Between 2014 and 2025, approximately 70% of the $13.9 billion in private quantum sector investments focused on hardware and components. Novo Holdings reports that funding for business-oriented applications remains insufficient relative to their potential value.
As of September 2, 2026, disclosed private funding for quantum companies reached $4.797 billion, surpassing the total of $4.706 billion recorded for the entire year of 2025. Analysts suggest the next development phase requires investment in specialized algorithms and services.
Novo Holdings highlights life sciences and pharmaceuticals as key areas. Early fault-tolerant quantum computers are expected to handle specific tasks, such as calculating chemical bond behavior, while classical computers manage the remaining processes.
The report outlines two development scenarios: early fault-tolerant systems emerging between the late 2020s and early 2030s, and larger-scale systems appearing from the mid-2030s. Risks include rapid advancements in classical computing and AI, which may reduce the competitive edge of quantum methods.
